What's new

ARPANSA recently partnered with the Australian Safeguards and Non-Proliferation Office (ASNO) to host a radionuclide workshop for Comprehensive Nuclear-Test-Ban Treaty local operators. Image courtesy of ASNO.

Low dose chest CT scans have been added to Australia’s national diagnostic reference levels to support optimisation of patients’ radiation exposure.

The CEO of ARPANSA gives notice that she intends to make a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 regarding Application No A01075 by the Australian Submarine Agency, for a facility licence.

Archaeological uses of radiation were among the topics discussed at the Commonwealth regulator’s annual licence holder forum held in Canberra on 30 May.

Monash University and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) are supervising a groundbreaking new study investigating adverse effects of energy-based cosmetic treatments in Australia.

ARPANSA presented Australia’s 2024 National Report at the recent International Atomic Energy Agency Joint Convention, demonstrating how Australia meets its international obligations regarding the safe management of radioactive waste.

As required by the Australian Radiation Protection and Nuclear Safety Regulations 2018 (the Regulations), the CEO of ARPANSA gives notice she intends to make a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 (the Act) regarding the application no. A01098 by the Australian Nuclear Science and Technology Organisation (ANSTO).

The national code that ensures radiation safety for patients and workers at dental clinics has been updated following international scientific assessment showing exposures in the dentist’s chair are very low.

Radiation protection authorities in Ghana and Sri Lanka have received thousands of dosimeters from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) to help keep radiation workers in these countries safe.

The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) recently delivered a comprehensive five-day training workshop to expand its emergency response capabilities.

The CEO of ARPANSA hereby gives notice of her intention to make a decision under section 32 of the Australian Radiation Protection and Nuclear Safety Act 1998 regarding an application for a facility licence by the Department of Defence to operate a prescribed radiation facility at Port Wakefield in South Australia.

A World Health Organization (WHO)-commissioned systematic review finds no association between radio wave exposure and various cancers including leukemia, lymphoma, thyroid and oral cavity cancers.

ARPANSA is encouraging all Australians to download the free, easy to use SunSmart Global UV app to help protect them from overexposure to the sun this summer.

ARPANSA is seeking nominations for two part-time members to join its peak advisory body, the Radiation Health and Safety Advisory Council (the ‘Council’).

The Australian Government’s nuclear regulator, the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) Chief Executive Officer, has approved the first stage of decommissioning of Australia’s original nuclear research reactor.

ARPANSA’s Australian Clinical Dosimetry Service (ACDS) was highlighted as a case study in the 2023-2024 Australian Public Service Commission State of the Service Report, which was tabled in parliament on 26 November 2024.

Medical physicists at the Australian Radiation Protection and Nuclear Safety Agency have worked with the International Atomic Energy Agency to develop a global radiotherapy audit method.

The 2023-24 Annual Report of ARPANSA has been tabled in Parliament and is now available to read on our website and the Federal Government's Transparency Portal.